These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 8840263

  • 1. Mechanism of lithium-induced polyuria in the rat.
    Carney SL, Ray C, Gillies AH.
    Kidney Int; 1996 Aug; 50(2):377-83. PubMed ID: 8840263
    [Abstract] [Full Text] [Related]

  • 2. Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats.
    Christensen S, Kusano E, Yusufi AN, Murayama N, Dousa TP.
    J Clin Invest; 1985 Jun; 75(6):1869-79. PubMed ID: 2989335
    [Abstract] [Full Text] [Related]

  • 3. Cellular mechanism of lithium-induced nephrogenic diabetes insipidus in rats.
    Yamaki M, Kusano E, Tetsuka T, Takeda S, Homma S, Murayama N, Asano Y.
    Am J Physiol; 1991 Sep; 261(3 Pt 2):F505-11. PubMed ID: 1716061
    [Abstract] [Full Text] [Related]

  • 4. Inhibition by lithium of the hydroosmotic action of vasopressin in the isolated perfused cortical collecting tubule of the rabbit.
    Cogan E, Abramow M.
    J Clin Invest; 1986 May; 77(5):1507-14. PubMed ID: 3700653
    [Abstract] [Full Text] [Related]

  • 5. P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.
    Zhang Y, Peti-Peterdi J, Müller CE, Carlson NG, Baqi Y, Strasburg DL, Heiney KM, Villanueva K, Kohan DE, Kishore BK.
    J Am Soc Nephrol; 2015 Dec; 26(12):2978-87. PubMed ID: 25855780
    [Abstract] [Full Text] [Related]

  • 6. Reverse pharmacological effect of loop diuretics and altered rBSC1 expression in rats with lithium nephropathy.
    Michimata M, Fujita S, Araki T, Mizukami K, Kazama I, Muramatsu Y, Suzuki M, Kimura T, Sasaki S, Imai Y, Matsubara M.
    Kidney Int; 2003 Jan; 63(1):165-71. PubMed ID: 12472779
    [Abstract] [Full Text] [Related]

  • 7. Upregulation of the expression of vasopressin gene in the paraventricular and supraoptic nuclei of the lithium-induced diabetes insipidus rat.
    Anai H, Ueta Y, Serino R, Nomura M, Kabashima N, Shibuya I, Takasugi M, Nakashima Y, Yamashita H.
    Brain Res; 1997 Oct 24; 772(1-2):161-6. PubMed ID: 9406968
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria.
    Sugawara M, Hashimoto K, Ota Z.
    Am J Physiol; 1988 Jun 24; 254(6 Pt 2):R863-9. PubMed ID: 2454589
    [Abstract] [Full Text] [Related]

  • 10. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity.
    Li Y, Shaw S, Kamsteeg EJ, Vandewalle A, Deen PM.
    J Am Soc Nephrol; 2006 Apr 24; 17(4):1063-72. PubMed ID: 16495377
    [Abstract] [Full Text] [Related]

  • 11. Sildenafil reduces polyuria in rats with lithium-induced NDI.
    Sanches TR, Volpini RA, Massola Shimizu MH, Bragança AC, Oshiro-Monreal F, Seguro AC, Andrade L.
    Am J Physiol Renal Physiol; 2012 Jan 01; 302(1):F216-25. PubMed ID: 22031848
    [Abstract] [Full Text] [Related]

  • 12. Lithium induced polyuria and renal vasopressin receptor density.
    Hensen J, Haenelt M, Gross P.
    Nephrol Dial Transplant; 1996 Apr 01; 11(4):622-7. PubMed ID: 8671849
    [Abstract] [Full Text] [Related]

  • 13. Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.
    de Groot T, Doornebal J, Christensen BM, Cockx S, Sinke AP, Baumgarten R, Bedford JJ, Walker RJ, Wetzels JFM, Deen PMT.
    Am J Physiol Renal Physiol; 2017 Sep 01; 313(3):F669-F676. PubMed ID: 28615247
    [Abstract] [Full Text] [Related]

  • 14. Lithium treatment induces a marked proliferation of primarily principal cells in rat kidney inner medullary collecting duct.
    Christensen BM, Kim YH, Kwon TH, Nielsen S.
    Am J Physiol Renal Physiol; 2006 Jul 01; 291(1):F39-48. PubMed ID: 16434572
    [Abstract] [Full Text] [Related]

  • 15. Potential role of purinergic signaling in lithium-induced nephrogenic diabetes insipidus.
    Zhang Y, Nelson RD, Carlson NG, Kamerath CD, Kohan DE, Kishore BK.
    Am J Physiol Renal Physiol; 2009 May 01; 296(5):F1194-201. PubMed ID: 19244398
    [Abstract] [Full Text] [Related]

  • 16. Genetic deletion of the P2Y2 receptor offers significant resistance to development of lithium-induced polyuria accompanied by alterations in PGE2 signaling.
    Zhang Y, Pop IL, Carlson NG, Kishore BK.
    Am J Physiol Renal Physiol; 2012 Jan 01; 302(1):F70-7. PubMed ID: 21975874
    [Abstract] [Full Text] [Related]

  • 17. Lithium-induced nephrogenic diabetes insipidus: in vivo and in vitro studies.
    Singer I, Rotenberg D, Puschett JB.
    J Clin Invest; 1972 May 01; 51(5):1081-91. PubMed ID: 4341501
    [Abstract] [Full Text] [Related]

  • 18. Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.
    Kishore BK, Carlson NG, Ecelbarger CM, Kohan DE, Müller CE, Nelson RD, Peti-Peterdi J, Zhang Y.
    Acta Physiol (Oxf); 2015 Jun 01; 214(2):176-88. PubMed ID: 25877068
    [Abstract] [Full Text] [Related]

  • 19. Failure of infusion of prostaglandin A2 to restore the response to antidiuretic hormone in rats with polyuria induced by lithium.
    Christensen S.
    J Endocrinol; 1980 Mar 01; 84(3):459-65. PubMed ID: 7391718
    [Abstract] [Full Text] [Related]

  • 20. Chlorpromazine increases the lowered response to antidiuretic hormone in rats with lithium-induced diabetes insipidus.
    Kristensen AR, Hammer M, Christensen S.
    Acta Pharmacol Toxicol (Copenh); 1985 Jan 01; 56(1):63-8. PubMed ID: 3976404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.